]>
IRCT20191111045400N1 IRCT 2021-08-14 Bojnourd University of Medical Sciences COVID-19 patients receiving with Ionic Plasma Cluster Technology Evaluation of the effect of Ionic Plasma Cluster Technology on the improvement of symptoms in patients with COVID-19 2021-07-23 anticipated 60 Complete https://irct.ir/trial/57434 interventional Randomization: Not randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Blinding description: The study was double-blind so that participants and data analyzers were not aware of the contents of the intervention package. N/A Covid-19. Intervention 1: Intervention group: 30 people receiving plasma cluster and routine treatment. Intervention 2: Control group: Routine treatment equal to 30 people. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no more information
public mohammad amin younesi
No.5, Shahriyar St, North Khorasan University of Medical sciences, Bojnurd, Iran
bojnurd Iran (Islamic Republic of) 9417694780 +98 58 3229 6769 a.younessi7@gmail.com Bojnourd University of Medical Sciences scientific mohammad reza taghavi
No.5, Shahriar St., Bojnurd, Iran
bojnurd Iran (Islamic Republic of) 9417694780 +98 58 3229 7182 taghavimr@yahoo.com Bojnourd University of Medical Sciences Iran (Islamic Republic of) Mild to moderate-grade Covid-19 patients Since the start of their symptoms, a maximum of 7 days have elapsed. Between the ages of 18 and 50, Fill out the informed consent form and sign it. 18 years 50 years Both Women who are pregnant or breastfeeding Using immunosuppressive medications Using sedatives and serotonin reuptake inhibitors Addiction to drugs underlying illness (chronic kidney and liver disease; brain and heart disease, pulmonary and hypertension; cancer, endocrine and metabolic diseases; thyroid disorders; immune deficiencies, Alzheimer's, multifocal failure, encephalopathy, and neuropathy) U07.1 Covid-19 disease Treatment - Other Placebo Intervention group: 30 people receiving plasma cluster and routine treatment Control group: Routine treatment equal to 30 people Improve symptoms based on checklist. Timepoint: Patients are monitored before the study and monitored 24 hours after the intervention. Then patients at weekly intervals for 4 weeks after the intervention in terms of clinical improvement by measuring body temperature, cough (zero or mild). And myalgia that is stable for at least 24 hours or the patient is hospitalized. Method of measurement: Researcher checklist. Bojnourd University of Medical Sciences Approved 2021-06-27 Ethics committee of North Khorasan University of Medical Sciences Shahriyar st, north khorasan university of medical sciences Bojnurd North Khorasan Iran (Islamic Republic of)